Patente

Patent (32)

  1. 1.
    Correia, C. A.; Gilmore, K.; McQuade, D. T.; Seeberger, P. H.: Process for the preparation of Efavirenz and devices suitable therefore. (2017)
  2. 2.
    Hofmann, J.; Hahm, H. S.; Seeberger, P. H.; Pagel, K.: Method for Determining Carbohydrates Structure. (2017)
  3. 3.
    Synthetic vaccines against Streptococcus pneumoniae serotype 8 . (2016)
  4. 4.
    Vaccines against Streptococcus pneumoniae serotype 4 . (2016)
  5. 5.
    Vaccine against carbapenem-resistant klebsiella pneumoniae. (2016)
  6. 6.
    Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
  7. 7.
    Antonietti, M.; Yuan, J.; Fechler, N.; Sakaushi, K.: Use of a poly(ionic liquid) as a binder material for electrodes in electrochemical devices . EP3016186 (A1) (2016)
  8. 8.
    Chakkumkal, A.; Lisboa, M.; Martin, C. E.; Pereira, C. L.; Seeberger, P. H.; Khan, N.: Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
  9. 9.
    Kopetzki, D.; McQuade, D. T.; Seeberger, P. H.; Gilmore, K.: Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives. WO2015007693 (2015)
  10. 10.
    Seeberger, P. H.; Pereira, C. L.: Synthetic vaccines against Streptococcus pneumoniae. (2015)
  11. 11.
    Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Schumann, B.: Synthetic vaccines against Streptococcus pneumoniae type 1. (2015)
  12. 12.
    Synthesis of diverse glycosylphosphatidylinositol glycans and glycolipids from toxoplasma gondii and their application as diagnostic markers and vaccines. (2014)
  13. 13.
    Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis. EP2766024 A1WO 2013041732 A1 (2014)
  14. 14.
    Azzouz, N.; Götze, S.; Seeberger, P. H.; Varón Silva, D.; Tsai, Y.-H.: Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics. (2014)
  15. 15.
    Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis. (2013)
  16. 16.
    Stabilization of carbon nanomaterials and hydrophobic compounds by copolymers . (2013)
  17. 17.
    Seeberger, P. H.; Stallforth, P.; De Libero, G.; Cavallari, M.: Polysaccharide antigen-glycolipid conjugate vaccines. EP2827899 (2013)
  18. 18.
    Seeberger, P. H.; Kopetzki, D.; Lévesque, F.: Method and device for the synthesis of Artemisinin. EP2751113 (2013)
  19. 19.
    Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)
  20. 20.
    Seeberger, P. H.; Stallforth, P.; Delibero, G.; Cavallari, M.: Carbohydrate-glycolipid conjugate vaccines. (2013)
 
loading content